Published in Arch Neurol on April 01, 1987
Which neuropsychiatric and behavioural features distinguish frontal and temporal variants of frontotemporal dementia from Alzheimer's disease? J Neurol Neurosurg Psychiatry (2000) 2.57
Cerebral correlates of psychotic symptoms in Alzheimer's disease. J Neurol Neurosurg Psychiatry (2000) 1.62
The diagnostic challenge of psychiatric symptoms in neurodegenerative disease: rates of and risk factors for prior psychiatric diagnosis in patients with early neurodegenerative disease. J Clin Psychiatry (2011) 1.40
Frontotemporal dementia and Alzheimer's disease: retrospective differentiation using information from informants. J Neurol Neurosurg Psychiatry (1995) 1.13
Neuropsychiatric profiles in patients with Alzheimer's disease and vascular dementia. J Neurol Neurosurg Psychiatry (2005) 1.11
Effects of low versus high frequencies of repetitive transcranial magnetic stimulation on cognitive function and cortical excitability in Alzheimer's dementia. J Neurol (2011) 1.06
Capgras syndrome in Dementia with Lewy Bodies. Int Psychogeriatr (2012) 1.03
Factors associated with psychotic symptoms in Alzheimer's disease. J Neurol Neurosurg Psychiatry (1998) 0.95
Transient musical hallucinosis of central origin: a review and clinical study. J Neurol Neurosurg Psychiatry (1992) 0.95
Presenile dementia syndromes: an update on taxonomy and diagnosis. J Neurol Neurosurg Psychiatry (2002) 0.95
Differential diagnosis of behavioral variant of fronto-temporal dementia (bvFTD). Med Sci Monit (2011) 0.83
Behavioural symptoms in dementia: nature and treatment. Indian J Psychiatry (1992) 0.81
Capgras' syndrome in dementia with Lewy bodies. J Geriatr Psychiatry Neurol (2002) 0.81
Early diagnosis of Alzheimer's disease from elevated olfactory mucosal miR-206 level. Sci Rep (2016) 0.79
A DKP cyclo(L-Phe-L-Phe) found in chicken essence is a dual inhibitor of the serotonin transporter and acetylcholinesterase. PLoS One (2012) 0.77
Psychiatric symptoms in dementia associated with stroke: a case-control analysis among predominantly African-American patients. J Natl Med Assoc (1994) 0.76
Quantifying the accretion of hyperphosphorylated tau in the locus coeruleus and dorsal raphe nucleus: the pathological building blocks of early Alzheimer's Disease. Neuropathol Appl Neurobiol (2017) 0.76
Treating Psychotic Symptoms in Elderly Patients. Prim Care Companion J Clin Psychiatry (2001) 0.75
["The living image sign" in a patient with Alzheimer's disease]. J Psychiatry Neurosci (1996) 0.75
Neuropsychiatric symptoms in patients with vascular dementia in mainland China. Transl Neurosci (2015) 0.75
Optimal treatment of Alzheimer's disease psychosis: challenges and solutions. Neuropsychiatr Dis Treat (2014) 0.75
Treatment of the special patient with schizophrenia. Dialogues Clin Neurosci (2001) 0.75
Neuropathological and neuroradiological correlates of paranoid symptoms in organic mental disease. Eur Arch Psychiatry Clin Neurosci (1997) 0.75
Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology (1993) 16.92
Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. Arch Neurol (2001) 9.96
The pyroptosome: a supramolecular assembly of ASC dimers mediating inflammatory cell death via caspase-1 activation. Cell Death Differ (2007) 7.74
Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2001) 7.68
Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2001) 7.51
Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory. J Neuropsychiatry Clin Neurosci (2000) 6.54
Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome. JAMA (2001) 5.13
Signaling mechanisms underlying the vascular myogenic response. Physiol Rev (1999) 4.89
Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. Proc Natl Acad Sci U S A (2000) 4.85
Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nat Biotechnol (2001) 4.54
School-based programs to reduce sexual risk behaviors: a review of effectiveness. Public Health Rep (1994) 4.50
The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. Kidney Int (2011) 4.27
Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2001) 3.74
Biochemical markers in persons with preclinical familial Alzheimer disease. Neurology (2008) 3.54
School-based screening for tuberculous infection. A cost-benefit analysis. JAMA (1995) 3.47
Are amyotrophic lateral sclerosis patients cognitively normal? Neurology (2003) 3.21
A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting. J Am Geriatr Soc (2001) 3.20
The spectrum of behavioral changes in Alzheimer's disease. Neurology (1996) 2.97
Consensus statement on the upcoming crisis in geriatric mental health: research agenda for the next 2 decades. Arch Gen Psychiatry (1999) 2.89
Cortical change in Alzheimer's disease detected with a disease-specific population-based brain atlas. Cereb Cortex (2001) 2.88
High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype. Arch Neurol (1998) 2.77
Breast cancer among black and white women in the 1980s. Changing patterns in the United States by race, age, and extent of disease. Cancer (1993) 2.70
Subcortical dementia. Review of an emerging concept. Arch Neurol (1984) 2.65
Neurobehavioral effects of phenytoin prophylaxis of posttraumatic seizures. JAMA (1991) 2.64
Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease. Ann Neurol (1995) 2.62
Frontal-subcortical circuits and neuropsychiatric disorders. J Neuropsychiatry Clin Neurosci (1994) 2.59
Telomere shortening in T cells correlates with Alzheimer's disease status. Neurobiol Aging (2002) 2.46
Alzheimer disease and frontotemporal dementias. Behavioral distinctions. Arch Neurol (1996) 2.45
Frontal lobe degeneration: clinical, neuropsychological, and SPECT characteristics. Neurology (1991) 2.43
Hydroxyurea enhances fetal hemoglobin production in sickle cell anemia. J Clin Invest (1984) 2.43
2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004). Ann Oncol (2005) 2.33
Early retinal damage in experimental diabetes: electroretinographical and morphological observations. Exp Eye Res (2002) 2.32
Neuropsychiatric correlates and treatment of lenticulostriatal diseases: a review of the literature and overview of research opportunities in Huntington's, Wilson's, and Fahr's diseases. A report of the ANPA Committee on Research. American Neuropsychiatric Association. J Neuropsychiatry Clin Neurosci (1998) 2.28
Haptoglobin phenotype and diabetic nephropathy. Diabetologia (2001) 2.27
Airway smooth muscle, tidal stretches, and dynamically determined contractile states. Am J Respir Crit Care Med (1997) 2.26
Apathy is not depression. J Neuropsychiatry Clin Neurosci (1998) 2.24
Sequence and analysis of chromosome 5 of the plant Arabidopsis thaliana. Nature (2000) 2.16
Deformation tensor morphometry of semantic dementia with quantitative validation. Neuroimage (2004) 2.14
Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17. Proc Natl Acad Sci U S A (1998) 2.13
The mechanism of lysis in phage T4-infected cells. Virology (1967) 2.12
Range of neuropsychiatric disturbances in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry (1999) 2.07
Neuropsychiatric aspects of Huntington's disease. J Neurol Neurosurg Psychiatry (2001) 2.04
Subcortical dementia. Neuropsychology, neuropsychiatry, and pathophysiology. Br J Psychiatry (1986) 1.96
The occurrence of depression in Parkinson's disease. A community-based study. Arch Neurol (1996) 1.94
The limbic system: an anatomic, phylogenetic, and clinical perspective. J Neuropsychiatry Clin Neurosci (1997) 1.93
Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. The HGEU Study Group. Arch Gen Psychiatry (2000) 1.93
A comparative analysis of ADL questions in surveys of older people. J Gerontol B Psychol Sci Soc Sci (1997) 1.91
Visual hallucinations. Clinical occurrence and use in differential diagnosis. West J Med (1987) 1.91
The role of retinal pigment epithelium in the involution of subretinal neovascularization. Invest Ophthalmol Vis Sci (1986) 1.90
Assessing the impact of neuropsychiatric symptoms in Alzheimer's disease: the Neuropsychiatric Inventory Caregiver Distress Scale. J Am Geriatr Soc (1998) 1.88
The morphology of human pronuclear embryos is positively related to blastocyst development and implantation. Hum Reprod (2000) 1.82
Assessment of CSF levels of tau protein in mildly demented patients with Alzheimer's disease. Neurology (1997) 1.78
The temporal variant of frontotemporal dementia. Brain (1997) 1.76
Calcium measurement in isolated arterioles during myogenic and agonist stimulation. Am J Physiol (1991) 1.75
Behavioral disorders and caregivers' reaction in Taiwanese patients with Alzheimer's disease. Int Psychogeriatr (2001) 1.72
Cortical variability and asymmetry in normal aging and Alzheimer's disease. Cereb Cortex (1998) 1.70
Finasteride in the treatment of men with frontal male pattern hair loss. J Am Acad Dermatol (1999) 1.67
Neuropsychiatric symptoms in patients with Parkinson's disease and dementia: frequency, profile and associated care giver stress. J Neurol Neurosurg Psychiatry (2006) 1.67
Impaired peripheral vasomotion in diabetes. Diabetes Care (1996) 1.67
Chronic divalproex sodium use and brain atrophy in Alzheimer disease. Neurology (2011) 1.66
Cerebral correlates of psychotic symptoms in Alzheimer's disease. J Neurol Neurosurg Psychiatry (2000) 1.62
Prevalence and severity of lifetime physical and sexual victimization among incarcerated women. Int J Law Psychiatry (1999) 1.62
The Clinician Assessment of Fluctuation and the One Day Fluctuation Assessment Scale. Two methods to assess fluctuating confusion in dementia. Br J Psychiatry (2000) 1.61
Utilization of Alzheimer's disease community resources by Asian-Americans in California. Int J Geriatr Psychiatry (2000) 1.56
Vascular dementia and dementia of the Alzheimer type. Cognition, ventricular size, and leuko-araiosis. Arch Neurol (1988) 1.54
Cognitive function in non-demented older adults with hypothyroidism. J Am Geriatr Soc (1992) 1.51
The insistent call from functional MRI. Neurology (1997) 1.50
Encephalitis lethargica: lessons for contemporary neuropsychiatry. J Neuropsychiatry Clin Neurosci (1995) 1.49
Health-care expenditures for tuberculosis in the United States. Arch Intern Med (1995) 1.48
Depression in epilepsy. Significance and phenomenology. Arch Neurol (1986) 1.48
Neuropsychiatric disturbances associated with idiopathic calcification of the basal ganglia. Biol Psychiatry (1983) 1.48
The fluorodeoxyglucose 18F scan in Alzheimer's disease and multi-infarct dementia. Arch Neurol (1983) 1.47
Sleep-disordered breathing in stable methadone programme patients: a pilot study. Addiction (2001) 1.46
The use of the neuropsychiatric inventory in nursing home residents. Characterization and measurement. Am J Geriatr Psychiatry (2000) 1.46
Causes and costs of hospitalization of tuberculosis patients in the United States. Int J Tuberc Lung Dis (2000) 1.45
Seven days of erythromycin estolate is as effective as fourteen days for the treatment of Bordetella pertussis infections. Pediatrics (1997) 1.43
Skin reactions at the application site of rivastigmine patch (4.6 mg/24 h, 9.5 mg/24 h or 13.3 mg/24 h): a qualitative analysis of clinical studies in patients with Alzheimer's disease. Int J Clin Pract (2015) 1.43
Decreased analyte transport through implanted membranes: differentiation of biofouling from tissue effects. J Biomed Mater Res (2001) 1.41
Neuropsychiatric aspects of progressive supranuclear palsy. Neurology (1996) 1.41
Sneddon's syndrome is a thrombotic vasculopathy: neuropathologic and neuroradiologic evidence. Neurology (1995) 1.40
Functional correlates of musical and visual ability in frontotemporal dementia. Br J Psychiatry (2000) 1.40
Regulation of ion channels by protein tyrosine phosphorylation. Am J Physiol Heart Circ Physiol (2001) 1.39
Assessment of cerebral perfusion using quantitative EEG cordance. Psychiatry Res (1994) 1.38
Behavioral syndromes in Alzheimer's disease: description and correlates. Dement Geriatr Cogn Disord (1999) 1.37
Utility of clinical criteria in differentiating frontotemporal lobar degeneration (FTLD) from AD. Neurology (2002) 1.37
Kluver-Bucy syndrome in Pick disease: clinical and pathologic correlations. Neurology (1981) 1.37
Orbitofrontal and anterior cingulate cortex neurofibrillary tangle burden is associated with agitation in Alzheimer disease. Ann Neurol (2001) 1.37
Dementia and neurodevelopmental predisposition: cognitive dysfunction in presymptomatic subjects precedes dementia by decades in frontotemporal dementia. Ann Neurol (2001) 1.34
Repetitive and compulsive behavior in frontal lobe degenerations. J Neuropsychiatry Clin Neurosci (1994) 1.33
Prevalence of tics in schoolchildren and association with placement in special education. Neurology (2001) 1.32
MRI evaluation of brain iron in earlier- and later-onset Parkinson's disease and normal subjects. Magn Reson Imaging (1999) 1.31
Evaluating dementia screening tests: methodologic standards to rate their performance. Neurology (1999) 1.30
Frequency of dementia in Parkinson disease. Arch Neurol (1996) 1.30
Aggressive, socially disruptive and antisocial behaviour associated with fronto-temporal dementia. Br J Psychiatry (1997) 1.30
Depressive symptomatology in middle-aged and older married couples: a dyadic analysis. J Gerontol B Psychol Sci Soc Sci (2001) 1.29
Neuropsychiatric manifestations of multiple sclerosis. J Neuropsychiatry Clin Neurosci (1999) 1.29
Serine/threonine protein phosphatase 5 (PP5) participates in the regulation of glucocorticoid receptor nucleocytoplasmic shuttling. BMC Cell Biol (2001) 1.28
Suicide from river bridges. Aust N Z J Psychiatry (1990) 1.27